TREST

Pre-Launch

methixene hydrochloride

NDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
9

Clinical Trials (5)

NCT06659393N/ARecruiting

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

Started Dec 2024
33 enrolled
Pediatric Chronic Heart Failure
NCT05976230N/ACompleted

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

Started Sep 2023
1,125 enrolled
Hypertension
NCT05870709N/AWithdrawn

Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure

Started May 2023
0
Heart Failure
NCT06604897N/AActive Not Recruiting

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

Started Jan 2023
1,405 enrolled
Essential Hypertension
NCT05848206N/ACompleted

Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.

Started Mar 2022
251,831 enrolled
Chronic Heart Failure